IMP-3 expression in melanocytic lesions
dc.contributor.author | Yu, Limin | en_US |
dc.contributor.author | Xu, Haodong | en_US |
dc.contributor.author | Wasco, Matthew J. | en_US |
dc.contributor.author | Bourne, Patricia A. | en_US |
dc.contributor.author | Ma, Linglei | en_US |
dc.date.accessioned | 2010-06-01T22:32:03Z | |
dc.date.available | 2010-06-01T22:32:03Z | |
dc.date.issued | 2010-03 | en_US |
dc.identifier.citation | Yu, Limin; Xu, Haodong; Wasco, Matthew J.; Bourne, Patricia A.; Ma, Linglei (2010). "IMP-3 expression in melanocytic lesions." Journal of Cutaneous Pathology 37(3): 316-322. <http://hdl.handle.net/2027.42/75517> | en_US |
dc.identifier.issn | 0303-6987 | en_US |
dc.identifier.issn | 1600-0560 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/75517 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19788446&dopt=citation | en_US |
dc.format.extent | 688687 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Copyright © 2010 John Wiley & Sons A/S | en_US |
dc.title | IMP-3 expression in melanocytic lesions | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Dermatology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, USA | en_US |
dc.contributor.affiliationother | Department of Pathology | en_US |
dc.contributor.affiliationother | Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA | en_US |
dc.identifier.pmid | 19788446 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/75517/1/j.1600-0560.2009.01428.x.pdf | |
dc.identifier.doi | 10.1111/j.1600-0560.2009.01428.x | en_US |
dc.identifier.source | Journal of Cutaneous Pathology | en_US |
dc.identifier.citedreference | Ries LMD, Krapcho M, Stinchcomb DG, et al. SEER cancer statistics review, 1975–2005. Bethesda, MD: National Cancer Institute, 2005. | en_US |
dc.identifier.citedreference | Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218. | en_US |
dc.identifier.citedreference | Nielsen FC, Nielsen J, Christiansen J. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking. Scand J Clin Lab Invest Suppl 2001; 234: 93. | en_US |
dc.identifier.citedreference | Mueller-Pillasch F, Pohl B, Wilda M, et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999; 88: 95. | en_US |
dc.identifier.citedreference | Jiang Z, Chu PG, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol 2006; 7: 556. | en_US |
dc.identifier.citedreference | Li C, Rock KL, Woda BA, Jiang Z, Fraire AE, Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007; 20: 242. | en_US |
dc.identifier.citedreference | Sitnikova L, Mendese G, Liu Q, et al. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res 2008; 14: 1701. | en_US |
dc.identifier.citedreference | Liao B, Hu Y, Herrick DJ, Brewer G. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005; 280: 18517. | en_US |
dc.identifier.citedreference | Wang T, Fan L, Watanabe Y, et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003; 88: 887. | en_US |
dc.identifier.citedreference | Pryor JG, Bourne PA, Yang Q, Spaulding BO, Scott GA, Xu H. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol 2008; 21: 431. | en_US |
dc.identifier.citedreference | Thomas AJ, Erickson CA. The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res 2008; 21: 598. | en_US |
dc.identifier.citedreference | Greene FLPD, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M, eds. AJCC cancer staging manual, 6th ed. New York: Springer, 2002. | en_US |
dc.identifier.citedreference | Jiang Z, Lohse CM, Chu PG, et al. Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer 2008; 112: 2676. | en_US |
dc.identifier.citedreference | Busam KJ. Cutaneous desmoplastic melanoma. Adv Anat Pathol 2005; 12: 92. | en_US |
dc.identifier.citedreference | Quinn MJ, Crotty KA, Thompson JF, Coates AS, O’Brien CJ, McCarthy WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998; 83: 1128. | en_US |
dc.identifier.citedreference | Smithers BM, McLeod GR, Little JH. Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases. Aust N Z J Surg 1990; 60: 967. | en_US |
dc.identifier.citedreference | Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol 1989; 13: 358. | en_US |
dc.identifier.citedreference | Wasco MJ, Pu RT, Yu L, Su L, Ma L. Expression of gamma-H2AX in melanocytic lesions. Hum Pathol 2008; 39: 1614. | en_US |
dc.identifier.citedreference | Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol 2006; 19: S21. | en_US |
dc.identifier.citedreference | Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol 1999; 30: 513. | en_US |
dc.identifier.citedreference | Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528. | en_US |
dc.identifier.citedreference | Ludgate MW, Fullen DR, Lee J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer 2009; 115: 631. | en_US |
dc.identifier.citedreference | Kapur P, Selim MA, Roy LC, Yegappan M, Weinberg AG, Hoang MP. Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis. Mod Pathol 2005; 18: 197. | en_US |
dc.identifier.citedreference | Kanter-Lewensohn L, Hedblad MA, Wejde J, Larsson O. Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. Mod Pathol 1997; 10: 917. | en_US |
dc.identifier.citedreference | Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 1998; 58: 2170. | en_US |
dc.identifier.citedreference | Harvell JD, Kohler S, Zhu S, Hernandez-Boussard T, Pollack JR, van de Rijn M. High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas. Diagn Mol Pathol 2004; 13: 22. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.